Deletion of donor-reactive T cell clones after human liver transplant
- PMID: 31509321
- PMCID: PMC6984984
- DOI: 10.1111/ajt.15592
Deletion of donor-reactive T cell clones after human liver transplant
Abstract
We recently developed a high throughput T cell receptor β chain (TCRβ) sequencing-based approach to identifying and tracking donor-reactive T cells. To address the role of clonal deletion in liver allograft tolerance, we applied this method in samples from a recent randomized study, ITN030ST, in which immunosuppression withdrawal was attempted within 2 years of liver transplantation. We identified donor-reactive T cell clones via TCRβ sequencing following a pre-transplant mixed lymphocyte reaction and tracked these clones in the circulation following transplantation in 3 tolerant and 5 non-tolerant subjects. All subjects showed a downward trend and significant reductions in donor-reactive TCRβ sequences were detected post-transplant in 6 of 8 subjects, including 2 tolerant and 4 non-tolerant recipients. Reductions in donor-reactive TCRβ sequences were greater than those of all other TCRβ sequences, including 3rd party-reactive sequences, in all 8 subjects, demonstrating an impact of the liver allograft after accounting for repertoire turnover. Although limited by patient number and heterogeneity, our results suggest that partial deletion of donor-reactive T cell clones may be a consequence of liver transplantation and does not correlate with success or failure of early immunosuppression withdrawal. These observations underscore the organ- and/or protocol-specific nature of tolerance mechanisms in humans.
Keywords: T cell biology; basic (laboratory) research/science; immunobiology; liver transplantation/hepatology; monitoring: immune; tolerance.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.
Conflict of interest statement
DISCLOSURE
The authors of this manuscript have conflicts of interest to disclose as described by the
Figures





Similar articles
-
Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients.Sci Transl Med. 2015 Jan 28;7(272):272ra10. doi: 10.1126/scitranslmed.3010760. Sci Transl Med. 2015. PMID: 25632034 Free PMC article.
-
Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts.Front Immunol. 2021 Oct 14;12:750005. doi: 10.3389/fimmu.2021.750005. eCollection 2021. Front Immunol. 2021. PMID: 34721420 Free PMC article.
-
Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipients.EBioMedicine. 2024 Aug;106:105239. doi: 10.1016/j.ebiom.2024.105239. Epub 2024 Jul 13. EBioMedicine. 2024. PMID: 38996766 Free PMC article. Clinical Trial.
-
Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives.Front Immunol. 2022 Jan 5;12:791725. doi: 10.3389/fimmu.2021.791725. eCollection 2021. Front Immunol. 2022. PMID: 35069574 Free PMC article. Review.
-
Cellular basis of long-term organ transplant acceptance: pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance.Am J Kidney Dis. 1998 Feb;31(2):197-212. doi: 10.1053/ajkd.1998.v31.pm9469488. Am J Kidney Dis. 1998. PMID: 9469488 Review.
Cited by
-
Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans.Sci Transl Med. 2022 Nov 2;14(669):eabo2628. doi: 10.1126/scitranslmed.abo2628. Epub 2022 Nov 2. Sci Transl Med. 2022. PMID: 36322627 Free PMC article. Clinical Trial.
-
Induction Phase of Spontaneous Liver Transplant Tolerance.Front Immunol. 2020 Sep 11;11:1908. doi: 10.3389/fimmu.2020.01908. eCollection 2020. Front Immunol. 2020. PMID: 33013840 Free PMC article. Review.
-
Strategies for Deliberate Induction of Immune Tolerance in Liver Transplantation: From Preclinical Models to Clinical Application.Front Immunol. 2020 Jul 31;11:1615. doi: 10.3389/fimmu.2020.01615. eCollection 2020. Front Immunol. 2020. PMID: 32849546 Free PMC article. Review.
-
Integrated Analysis Toolset for Defining and Tracking Alloreactive T-cell Clones After Human Solid Organ and Hematopoietic Stem Cell Transplantation.Softw Impacts. 2021 Nov;10:100142. doi: 10.1016/j.simpa.2021.100142. Epub 2021 Sep 23. Softw Impacts. 2021. PMID: 35291378 Free PMC article.
-
Editorial: Immunogenomics of Solid Organ and Hematopoietic Stem Cell Transplantation.Front Immunol. 2022 Mar 16;13:878314. doi: 10.3389/fimmu.2022.878314. eCollection 2022. Front Immunol. 2022. PMID: 35371062 Free PMC article. No abstract available.
References
-
- Feng S, Ekong UD, Lobritto SJ, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA. 2012;307(3):283–293. - PubMed
-
- Benitez C, Londono MC, Miquel R, et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology. 2013;58(5):1824–1835. - PubMed
-
- Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992;103(1):317–322. - PubMed
-
- Tisone G, Orlando G, Cardillo A, et al. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol. 2006;44(4):702–709. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources